Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial

Ramzi A Tabbalat, Imad Alhaddad, Ayman Hammoudeh, Yousef S Khader, Hassan Abu Khalaf, Mohammad Obaidat, Jude Barakat, Ramzi A Tabbalat, Imad Alhaddad, Ayman Hammoudeh, Yousef S Khader, Hassan Abu Khalaf, Mohammad Obaidat, Jude Barakat

Abstract

Background: Studies using 1 mg of colchicine to prevent postoperative atrial fibrillation (POAF) reported conflicting results. Moreover, colchicine was associated with significant gastrointestinal (GI) side effects. This study examined whether low-dose colchicine effectively prevents POAF and whether low-dose therapy is associated with lower rates of colchicine-induced GI side effects.

Methods: In this prospective, randomized, double-blind, placebo-controlled study, consecutive adult patients admitted for elective cardiac surgeries randomly received a 1-mg dose of colchicine (n = 81) or placebo (n = 71) orally 12 to 24 hours before surgery followed by a daily dose of 0.5 mg until hospital discharge. The primary efficacy endpoint was the development of at least one episode of POAF of ≥5 minutes. The primary safety endpoint was the development of adverse events, especially diarrhea.

Results: The in-hospital mortality rate was 3.9%. POAF occurred in 13 patients (16.1%) in the colchicine group and 13 patients (18.3%) in the placebo group (odds ratio 0.85 [95% Confidence Interval = 0.37-1.99]). Diarrhea occurred in two patients in each group and necessitated treatment discontinuation in one patient in each group.

Conclusion: Low-dose colchicine did not prevent POAF in patients undergoing cardiac surgery. These results should be interpreted cautiously because of the small sample size and early study termination.ClinicalTrials.gov Unique Identifier number: NCT03015831.

Keywords: Atrial fibrillation; arrhythmia; cardiac surgery; colchicine; gastrointestinal toxicity; randomized controlled trial.

Figures

Figure 1.
Figure 1.
Flow diagram of study participation.
Figure 2.
Figure 2.
Rate of AF in different cardiac surgery groups.

References

    1. Lauer M, Eagle K, Buckley M, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–378.
    1. Filardo G, Damiano RJ, Jr, Ailawadi G, et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart 2018; 104: 985–992.
    1. Polat A, Şahin İ, Yücel C, et al. Coronary vasculature and postoperative atrial fibrillation: a risk factor analysis. Turk Gogus Kalp Dama 2013; 21: 567–573.
    1. Zaman A, Archbold R, Helft G, et al. Atrial Fibrillation After Coronary Artery Bypass Surgery. Circulation 2000; 101: 1403–1408.
    1. Nair S. Atrial fibrillation after cardiac surgery. Ann Card Anaesth 2010; 13: 196–205.
    1. Tamis J, Steinberg J. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol 2000; 23: 155–159.
    1. Lazar H, Fitzgerald C, Gross S, et al. Determinants of Length of Stay After Coronary Artery Bypass Graft Surgery. Circulation 1995; 92: 20–24.
    1. Alqahtani A. Atrial fibrillation post cardiac surgery trends toward management. Heart Views 2010; 11: 57–63.
    1. Chung M, Martin D, Sprecher D, et al. C-Reactive Protein Elevation in Patients with Atrial Arrhythmias. Circulation 2001; 104: 2886–2891.
    1. Ishii Y, Schuessler R, Gaynor S, et al. Inflammation of Atrium After Cardiac Surgery Is Associated with Inhomogeneity of Atrial Conduction and Atrial Fibrillation. Circulation 2005; 111: 2881–2888.
    1. Ishii Y, Schuessler R, Gaynor S, et al. Postoperative atrial fibrillation: the role of the inflammatory response. J Thorac Cardiovasc Surg 2017; 153: 1357–1365.
    1. Ho K, Tan J. Benefits and Risks of Corticosteroid Prophylaxis in Adult Cardiac Surgery. Circulation 2009; 119: 1853–1866.
    1. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Post pericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011; 124: 2290–2295.
    1. Imazio M, Brucato A, Ferrazzi P, et al. . Colchicine for Prevention of Post pericardiotomy Syndrome and Postoperative Atrial Fibrillation. The COPPS-2 randomized clinical trial. JAMA 2014; 312: 1016–1023.
    1. Vrachatis D, Kossyvakis C, Angelidis C, et al. Colchicine in Post-operative Atrial Fibrillation: a Review. Curr Pharm Des 2018; 24: 695–701.
    1. Tabbalat R, Hamad N, Alhaddad I, et al. Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial. Am Heart J 2016; 178: 102–107.
    1. Lee J, Singh N, Howe C, et al. Colchicine for Prevention of Post-Operative Atrial Fibrillation. JACC Clin Electrophysiol 2016; 2: 78–85.
    1. Lennerz C, Barman M, Tantawy M, et al. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis. Int J Cardiol 2017; 249: 127–137.
    1. Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment with Colchicine in Acute Myocardial Infarction. Circulation 2015; 132: 1395–1403.
    1. Nidorf S, Eikelboom J, Budgeon C, et al. Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease. J Am Coll Cardiol 2013; 61: 404–410.
    1. Tardif JC, Kouz S, Waters D, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019; 381: 2497–2505.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj